ODIN projects are inspired by unmet medical needs and industrial challenges, co-created by both companies and university researchers. Below are some of the key reasons to join ODIN as a company:
EASE OF COLLABORATION – ODIN offers a faster and more efficient way to enter academic collaborations. Since ODIN projects are precompetitive, there are no IP negotiations and less red tape. Before starting an ODIN project, all participants must sign a non-negotiable Project Agreement, which was pre-approved by ODIN’s founding companies and partner universities to ensure smooth collaboration. You can find the agreement under "About ODIN" on our website.
SCOUT NEW TECHNOLOGIES & ACCESS NEW RESOURCES – ODIN allows you to stay up to date with cutting-edge academic research while also providing opportunities to access clinical materials and other resources that you may have difficulty accessing in the private sector.
SOURCE INPUT & FIND PARTNERS – ODIN enables you to address unsolved challenges in your company’s R&D through needs-driven, precompetitive research. We help you identify the right input and partners—free of charge.
DE-RISK WILD IDEAS – ODIN provides a space for exploratory R&D and long-term knowledge-building, allowing you to engage in high-risk, high-reward projects that complement or extend your internal research efforts. Since ODIN covers the costs of the academic component of the research, your company can become involved at a much earlier stage with little financial risk.
ACCESS NEW TALENT – While ODIN projects are led by associate or full-professors at the top of their fields, they also involve non-tenured researchers who may be considering a future career in industry—giving your company early exposure to top talent.
BUILD STRATEGIC NETWORKS & CONTRIBUTE TO INDUSTRY ADVANCEMENT – Form valuable cross-sector collaborations with researchers, other companies, and healthcare institutions while supporting knowledge sharing that strengthens the entire ecosystem, driving industry-wide advancements in drug discovery and diagnostics.
In ODIN, there's no fighting over legal stuff. We use the same pre-negotiated project agreements for all funded projects. With our no-IP model, there is no need for IP negotiations.
"ODIN is not just for big pharma companies. There are also several reasons for joining ODIN as an SME. From the ODIN pilot project we know that it is an opportunity to showcase and develop your skills and expand your network at the same time. You will increase your visibility to both new collaborators and potential clients."
Marie Louise Conradsen, Head of ODIN
ODIN is not just a platform for large pharma and diagnostics companies. For small and medium-sized enterprises (SMEs), ODIN is an opportunity to engage in collaborative R&D despite limited internal resources. SMEs can:
Companies can also become part of the ODIN platform to strengthen networking and/or stay up-to-date on the progress of ODIN projects. If you are considering taking part in ODIN, here are a few things you should know:
Below you will find the link to our online platform, where you can register to become part of ODIN.
The project participants share the risk in high-risk/high-gain projects.